Previous 10 | Next 10 |
home / stock / pclo:cc / pclo:cc news
PharmaCielo Announces First Shipment of Pharmaceutical Grade Cannabis Extract to Customer in Morocco Canada NewsWire Represents PharmaCielo's first shipment to Africa . Morocco is pioneering the commercialization of cannabinoid products on the African continent and w...
PharmaCielo Announces TSX Venture Exchange Approval of Warrant Extension Canada NewsWire TORONTO and RIONEGRO, Colombia , Nov. 22, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of ...
PharmaCielo Announces Q3 2022 Financial Results Canada NewsWire In the first nine months of 2022, PharmaCielo has made shipments to 23 customers in nine countries, with continued growth expected for 2023. The Company has more than doubled Revenue to $3.8 million ...
PharmaCielo Announces Shipment of Pharmaceutical Grade Cannabis Extract to Customer in Uruguay Canada NewsWire This is PharmaCielo's second pharmaceutical grade product shipment to a well-established Latin American pharmaceutical company with operations in Uruguay ...
PharmaCielo Announces Shipment of Dried Cannabis Flower to the Czech Republic, Representing the Company's First Shipment of Medicinal Grade Dried Cannabis Flower into the EU Canada NewsWire Shipment made to an established pharmaceutical distributor and clinical resea...
PharmaCielo Announces Receipt of Production Quota of THC Dominant Dried Cannabis Flower for Export - Commercial Quantities of Flower Shipments to Begin in Early 2023 Canada NewsWire Colombian government has maintained its commitment to supporting its cannabis produce...
PharmaCielo Announces Q2 2022 Financial Results; Upsizes Oversubscribed Debenture Financing Canada NewsWire The Company continues to grow sales and expects to build momentum through the remainder of 2022 and through 2023, with recent progress in Israel , Brazil ...
PharmaCielo Announces Receipt of ICANN G.A.P and GACP Certifications, Opening Commercial Access to the Israeli Market Canada NewsWire The Company expects to begin exporting dried flower to Israel in early 2023. Israel is one of the largest importers o...
PharmaCielo Announces First Shipment to Mexican Joint Venture Partner Canada NewsWire The Company has made a pre-commercial shipment of CBD isolate to its Mexican joint venture, to support product development by a Mexican phytotherapeutic company. TORONTO...
PharmaCielo Announces Sales Agreement with Brazilian Phyto-Therapeutic Customer, and Key Management and Board Appointments Canada NewsWire TORONTO and RIONEGRO, Colombia , July 28, 2022 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:...
News, Short Squeeze, Breakout and More Instantly...
The proposed acquisition of Siam Ventures, which provides contract manufacturing services through a subsidiary, will act as a gateway to large Asian markets for PharmaCielo product. Experienced investor, businessman and lawyer Louis Desmarais, the current Chairman and CEO of Siam Ventures, w...
2024-03-27 17:08:02 ET CEO of PharmaCielo, David Attard speaks to shareholders about the short seller report In early March, Hindenburg Research issued a short seller report targeting PharmaCielo's credibility and its stock. Moreover, the Company believes that this report represen...
2024-03-27 17:08:02 ET A Canadian company with Colombian operations PharmaCielo is a global company, headquartered in Canada. They are focusing on ethical and sustainable processing and supplying of all natural, medicinal-grade cannabis oil extracts and related produ...